Russell LaMontagne

Russell LaMontagne is an accomplished professional with a strong background in geology, biology, and business. He holds a Master of Science in Geology and Geophysics from Yale University, as well as a Bachelor of Science in Biology and Geology from the University of Massachusetts Amherst. Russell has held various key positions in prominent organizations, currently serving as the President and CEO of Boston Immune Technologies and Therapeutics (BITT).

With a rich history of leadership roles, Russell has also been the Director at BCG and Autoimmunity, a Board Member at Endobiome, a Partner at Corinth Group, and an Account Executive at Edelman Public Relations. His diverse experience spans across different industries, showcasing his versatility and expertise in navigating complex business environments.